1. Home
  2. MMSI vs PBLS Comparison

MMSI vs PBLS Comparison

Compare MMSI & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merit Medical Systems Inc.

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$87.26

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$38.17

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMSI
PBLS
Founded
1987
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.6B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
MMSI
PBLS
Price
$87.26
$38.17
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$98.88
N/A
AVG Volume (30 Days)
449.0K
549.9K
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
4.93
N/A
EPS
1.33
N/A
Revenue
$1,515,906,000.00
N/A
Revenue This Year
$8.85
N/A
Revenue Next Year
$5.88
N/A
P/E Ratio
$64.28
N/A
Revenue Growth
11.75
N/A
52 Week Low
$59.74
$25.56
52 Week High
$94.75
$42.49

Technical Indicators

Market Signals
Indicator
MMSI
PBLS
Relative Strength Index (RSI) 41.97 47.73
Support Level $85.19 $26.42
Resistance Level $92.22 $41.34
Average True Range (ATR) 2.06 2.68
MACD -0.67 -0.30
Stochastic Oscillator 16.75 29.21

Price Performance

Historical Comparison
MMSI
PBLS

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: